Skip to content

To know the effect of vamana in the management of Kaphapradhana Vatarakta(Gouty Arthritis)

A Randomized Controlled Clinical Trial To Evaluate the Efficacy of Mrduvamana in Kaphapradhana Vatarakta (Gouty Arthritis) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072178
Enrollment
30
Registered
2024-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

None listed

Sponsors

Dr. Anivilla L P Vijaya Swapnika
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient fit for Vamana karma. Patients having signs and symptoms of Kaphapradhana Vatarakta (Gouty Arthritis).

Exclusion criteria

Exclusion criteria: Patients already diagnosed with Rheumatoid arthritis, Osteoarthritis, Osteoarthritis overlapping Gouty arthritis. Patients who are pregnant/ lactating women.

Design outcomes

Primary

MeasureTime frame
To reduce the signs and symptoms of Kaphapradhana Vatarakta (Gouty ArthritiS) assessed by using CDAI and improve Range of Movements of affected joint assessed by using Goniometer.Timepoint: Patients from both the groups will be assessed after 15 days.

Secondary

MeasureTime frame
To reduce serum uric acid levelsTimepoint: Patients from both the groups will be assessed on day 0 and day 60

Countries

India

Contacts

Public ContactDr Praveen B S

Sri Jayendra Saraswathi Ayurveda College and Hospital

praveenbs29@rediffmail.com9964006795

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026